HBV-IN-41
HBV-IN-41 (compound 45) is a potent and orally active Hepatitis B Virus (HBV) inhibitor, with an EC50 of 0.027μM[1].
Product Specifications
CAS Number
1967002-25-0
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-41.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1CN2C(CN1C(NC3=CC(Cl)=C(C=C3)F)=O)=C(C=N2)N4CCOCC4=O
Molecular Formula
C18H19ClFN5O3
Molecular Weight
407.83
References & Citations
[1]Kou B, et al. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. J Med Chem. 2023 Oct 6.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3079306 1.0 µg DNA
Prlh sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
K7476303 1.0 µg DNA
Olr1253 sgRNA CRISPR Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details